Global Cancer Research and Control Seminar Series 2025 (Upcoming Webinars)

Anant Madabhushi, Ph.D., Robert W. Woodruff Professor of Biomedical Engineering
Emory University

Anant Madabhushi, Ph.D., is the Robert W. Woodruff Professor of Biomedical Engineering and serves on the faculty in the Departments of Pathology, Biomedical Informatics, Urology, Radiation Oncology, Radiology and Imaging Sciences, Global Health and Computer and Information Sciences at Emory University. He is also a Research Career Scientist at the Atlanta Veterans Administration Medical Center and serves as the inaugural executive director of the newly formed Emory Empathetic AI for Health Institute. Dr. Madabhushi has authored over 500 peer-reviewed publications and holds more than 225 either issued or pending patents in the areas of artificial intelligence, radiomics, medical image analysis, computer-aided diagnosis, and computer vision.

Dr. Madabhushi is a Fellow of the American Institute of Medical and Biological Engineering (AIMBE), the Institute for Electrical and Electronic Engineers (IEEE), the American Association for the Advancement of Science (AAAS) and the National Academy of Inventors (NAI). His work on "Smart Imaging Computers for Identifying Lung Cancer Patients Who Need Chemotherapy" was recognized by Prevention Magazine as one of the top 10 medical breakthroughs of 2018. In 2019, Nature Magazine hailed him as one of 5 scientists developing "offbeat and innovative approaches for cancer research." From 2019 to 2022, Dr. Madabhushi was named to The Pathologist’s Power List of 100 inspirational and influential professionals in pathology. He is also an entrepreneur, having founded three companies: Elucid Bioimaging, Ibris Inc., and Picture Health. In 2019, Elucid Bioimaging attained FDA approval for one of his technologies on the use of AI for carotid plaque characterization.

Abstract

Amr Soliman, M.D., Ph.D., Director, Cancer Epidemiology Education in Special Populations (CEESP) Program
City University of New York (CUNY) School of Medicine

Over the past 25 years, Dr. Amr Soliman has collaborated with faculty members in various global settings and special populations in the United States to develop a program in cancer epidemiology and translation to cancer prevention and control. This collaboration has led to the development and maintenance of strong research infrastructure in global settings and with several medical centers in Africa, Asia, Latin America, and Eastern Europe to investigate the epidemiology of cancers relevant to the local sites. Dr. Soliman co-led the largest global research study on inflammatory breast cancer in North Africa, along with Dr. Catherine Schairer (retired) from the National Cancer Institute (NCI). He also co-led a project in Tanzania on HIV-related malignancies. His two global research studies have provided significant training opportunities to students and trainees from the United States and in global settings.

Over the past 20 years, Dr. Soliman has served as the principal investigator of the NCI-R25-supported Cancer Epidemiology Education in Special Populations (CEESP) program at the University of Michigan, the University of Nebraska, and City University of New York. The CEESP program has trained more than 250 public health and medical students in special populations. More than 98 percent of the CEESP alumni practice and conduct research in the United States after their global training.

Dr. Soliman has also conducted collaborative research with the minority-focused SEER registry in Detroit, MI; the Michigan Cancer Consortium; the State Cancer Registry of Michigan; and the Arab American Center for Social and Economic Services. He also conducted several research studies focused on underserved populations in Michigan, rural populations in Nebraska, and unique populations in New York. Dr. Soliman’s domestic research in the United States focuses on access to cancer care, screening, and early detection in underserved populations.

Dr. Soliman is the past president of the American Association for Cancer Education and the current editor-in-chief of the Journal of Cancer Education.

Nisreen Qatamish, Director General
King Hussein Cancer Foundation

Mrs. Nisreen Qatamish is a recognized leader in social development, philanthropy, and the advancement of women’s and youth issues. She currently serves as the Director General of the King Hussein Cancer Foundation (KHCF) in Jordan, the country's largest community-based nonprofit organization. Under Ms. Qatamish’s leadership, KHCF has solidified its position as a regional and international leader in cancer care. Mrs. Qatamish oversees fundraising and advocacy efforts, leads comprehensive communications and media strategies, fosters strong partnerships across the public and private sectors, and plays a key role in garnering government support for the Foundation. An advocate for long-term sustainability, Mrs. Qatamish has been instrumental in creating innovative financial strategies to secure the Foundation’s future. Notably, she spearheaded the establishment of the KHCF Endowment and led the development of a cancer insurance program, championing its nationwide expansion as a comprehensive and socially inclusive model for financing cancer treatment.
Mrs. Qatamish holds a bachelor’s degree in resource management and the environment from the University of Jordan. She has also completed specialized training in leadership, management, and policymaking at the American University of Beirut and the Harvard Kennedy School.

Abstract